Effects of adding transcutaneous vagus nerve stimulation to vestibular rehabilitation on dizziness and postural control in vestibular migraine: a randomized clinical trial
Abstract
Vestibular migraine (VM) causes episodic dizziness and imbalance, yet treatment options remain limited. Although management often follows migraine protocols, vestibular and headache symptoms may not coincide. While vestibular rehabilitation (VR) is a noninvasive approach to improve balance, transcutaneous auricular vagus nerve stimulation (taVNS) has shown promise in migraine relief and may influence vestibular function. This parallel-group randomized clinical trial investigated the combined effects of VR and taVNS on postural control and migraine-related symptoms in VM patients. Twenty-eight participants were randomly assigned to four groups: VR, taVNS, VR plus sham-taVNS, and VR plus taVNS. The one-month intervention included daily VR exercises and twelve 30-minute taVNS sessions targeting the cymba conchae. Outcomes comprised postural control parameters under four conditions as primary outcomes, and video head impulse test gain, Dizziness Handicap Inventory, Vertigo Symptom Scale–short form, vertigo/dizziness and headache frequency, and Headache Impact Test (HIT-6) scores as secondary outcomes. All groups showed significant improvement (p < 0.05), but VR plus taVNS produced the most consistent gains across postural and symptom measures. Groups receiving taVNS had greater reductions in headache frequency and HIT-6 scores (p < 0.05). Postural improvement moderately correlated with decreased vertigo/dizziness frequency. Combining taVNS with VR may enhance balance and symptom…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.